FULC Insider Holders & Insider Ownership - Fulcrum Therapeutics Inc.

List of insiders holdings for Fulcrum Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner	2024-09-23 16:15:29	0 18,729,099	18,729,099	Form 3
2	LEVIN MARK J Director 10% Owner	2021-11-12 17:31:37	75,800 4,970,625	5,046,425	Form 4
3	Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner	2020-02-05 16:33:55	2,343,154 0	2,343,154	Form 13G
4	Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I 10% Owner	2024-02-14 16:19:04	2,343,154 0	2,343,154	Form 13G
5	Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner	2024-02-14 16:19:04	2,343,154 0	2,343,154	Form 13G
6	GLAXOSMITHKLINE PLC 10% Owner	2021-09-27 06:01:18	1,785,714 0	1,785,714	Form 13G
7	Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli 10% Owner	2021-02-11 10:23:04	1,241,176 0	1,241,176	Form 13G
8	Sapir Alex See Remarks	2025-01-28 16:15:11	582,000 0	582,000	Form 4
9	6 Dimensions Capital L.P. 10% Owner	2019-07-22 16:32:02	559,821 0	559,821	Form 4
10	Sanofi 10% Owner	2019-07-29 10:13:05	558,035 0	558,035	Form 13G
11	Section 32 Fund 2 LP Section 32 GP 2 LLC Maris William J 10% Owner	2019-07-22 16:30:46	464,285 0	464,285	Form 4
12	Horn Patrick Taylor Chief Medical Officer	2024-03-20 16:15:10	400,000 0	400,000	Form 4
13	Arroyo Santiago Chief Medical Officer	2022-11-09 16:15:14	400,000 0	400,000	Form 4
14	Stuart Bryan See Remarks	2022-01-21 16:15:24	340,000 0	340,000	Form 4
15	Musso Alan A Chief Financial Officer	2025-01-28 16:15:14	285,000 0	285,000	Form 4
16	Oltmans Curtis Gale Chief Legal Officer	2025-01-28 16:15:06	225,000 0	225,000	Form 4
17	Wallace Owen B. Chief Scientific Officer	2020-09-14 16:19:08	209,030 0	209,030	Form 4
18	Moxham Christopher Chief Scientific Officer	2021-08-12 16:20:57	176,073 0	176,073	Form 4
19	Rajavelu Esther Chief Financial Officer	2023-02-13 16:15:14	160,000 0	160,000	Form 4
20	Dunn Judith See Remarks	2022-01-21 16:15:31	140,890 0	140,890	Form 4
21	Hayes Melvin H. III Chief Operating Officer	2023-04-28 16:17:16	115,000 0	115,000	Form 4
22	Tourangeau Greg Principal Accounting Officer	2025-01-28 16:15:08	76,120 0	76,120	Form 4
23	Cadavid Diego SVP Clinical Development	2020-07-02 16:19:30	65,714 0	65,714	Form 4
24	King Rachel K. Director	2024-11-14 16:15:03	60,000 0	60,000	Form 4
25	Hill Colin Director	2024-06-18 16:15:04	60,000 0	60,000	Form 4
26	Morabito Christopher Chief Medical Officer	2022-01-21 16:15:17	59,744 0	59,744	Form 4
27	Thomson Peter G. VP Finance & Accounting	2022-01-21 16:15:41	40,000 0	40,000	Form 4
28	Dorton Katina Director	2024-06-18 16:20:07	30,000 0	30,000	Form 4
29	GERAGHTY JAMES A Director	2024-06-18 16:20:09	30,000 0	30,000	Form 4
30	Haviland Kate Director	2024-06-18 16:20:13	30,000 0	30,000	Form 4
31	Gould Robert J Director	2024-06-18 16:20:14	30,000 0	30,000	Form 4
32	Ezekowitz Alan Director	2024-06-18 16:20:20	30,000 0	30,000	Form 4
33	Collins James J. Director	2024-06-18 16:20:06	30,000 0	30,000	Form 4
34	Banks Sonja Director	2024-06-18 16:20:03	30,000 0	30,000	Form 4

Insider Holders & Insider Ownership - Fulcrum Therapeutics Inc. (FULC)